Cost-utility analysis of interferon-free treatments for patients with early-stage genotype 1 hepatitis C virus in Brazil.
Vinicius Lins FerreiraLeticia Paula LeonartMaria Lucia Alves PedrosoRoberto PontaroloPublished in: Revista da Sociedade Brasileira de Medicina Tropical (2020)
The above findings were confirmed via probabilistic sensitivity analysis and the tested scenarios.